We observed that NASH patients showed higher levels of IL-6 associated with lower IL-10/IL-6 ratio when compared to controls, suggesting insufficient anti-inflammatory compensation in this group. Here, IL10 is linked to metabolic dysfunction-associated steatohepatitis.